- Supported exchanges /
- NASDAQ /
- TVGN.NASDAQ
Tevogen Bio Holdings Inc (TVGN NASDAQ) stock market data APIs
Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Tevogen Bio Holdings Inc Financial Data Overview
| 0.4574 | |
| 0.489 | |
| - | |
| 0.4899 | |
| 0.4411 | |
| 0.4-21.09 | |
| 165 M | |
| 165 M | |
| 0 | |
| -0.0394 | |
| 0.482 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Tevogen Bio Holdings Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -8 679 725
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Tevogen Bio Holdings Inc Earnings via APIs
- Latest Release 2024-08-14
- EPS/Forecast NaN
Get Tevogen Bio Holdings Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
